Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06236945

HUTT to Assess Cardiac Autonomic Nervous Function

Composite Autonomic Scoring Scale and HUTT to Assess Cardiac Autonomic Nervous Function: A Preliminary Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,122 (estimated)
Sponsor
The First Hospital of Hebei Medical University · Academic / Other
Sex
All
Age
12 Years – 85 Years
Healthy volunteers
Accepted

Summary

Autonomic nervous system diseases can cause abnormalities in the circulatory system, leading to malignant arrhythmia and sudden cardiac death. Standardized, operable, and simplified diagnostic indicators are urgently needed to evaluate autonomic nervous function, particularly cardiac autonomic nervous function. The investigators use HUTT in order to provide data support for cardiac autonomic nervous system evaluation.

Detailed description

In this study, 169 samples with vertical tilt test and 24-h Holter ECG data from February 13, 2023 to October 31, 2023 were selected. The AC, DC, and 24-h HRV were compared with the CASS to identify the indicators with the strongest correlation with the CASS sympathetic and vagus nerve scores. The best index was selected, and the score intervals were delimited. The sensitivity and specificity of the defined vagal and sympathetic intervals were analyzed.

Conditions

Timeline

Start date
2024-01-31
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2024-02-01
Last updated
2024-09-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06236945. Inclusion in this directory is not an endorsement.

HUTT to Assess Cardiac Autonomic Nervous Function (NCT06236945) · Clinical Trials Directory